Published on October 20, 2017
Dr. Fatima Cardoso from Champalinaud Cancer Center in Lisbon (Portugal) explains the research that is being done around immunotherapy for breast cancer. Researchers are studying which subtypes of breast cancer could benefit the most from immunotherapy and the best time to give immunotherapy in the progression of cancer.
This interview was recorded at the European Society of Medical Oncology (ESMO) congress held in Madrid (September 2017). Breast cancer videos recorded at ESMO 17 are part of an educational program by the Patient Empowerment Foundation (PEF). We thank Roche for their support.